Follow the people · Insider
Prashant Kohli
Prashant Kohli files insider transactions with the SEC as a chief executive officer of Grace Therapeutics. We hold 1 disclosed purchase or sale filed since 18 July 2023, 1 of them in the last 90 days.
- Files for 2 companiesGRCE, ACST
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 April 2025 — 9 September 2026Chief Executive Officer · Grace Therapeutics 3 Form 4 lines · source: SEC Form 4
- Filed 14 July 2023 — 6 May 2024Chief Executive Officer · Acasti Pharma 3 Form 4 lines · source: SEC Form 4
Every transaction
6 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 10 Sep 2026SEC Form 4 | 1 d | bought on the open market | Grace Therapeutics | 100,000 shares | up +3.7% | down −1.8% |
| 28 Aug 2026 | 1 Sep 2026SEC Form 4 | 4 d | was grantednot a trade | Grace Therapeuticsderivative | 267,160 shares | up +4.7% | up +5.7% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | was grantednot a trade | Grace Therapeuticsderivative | 225,400 shares | up +3.7% | up +8.8% |
| 6 May 2024 | 8 May 2024SEC Form 4 | 2 d | was grantednot a trade | Acasti Pharmaderivative | 128,770 shares | down −24.7% | down −23.2% |
| 19 Dec 2023 | 20 Dec 2023SEC Form 4 | 1 d | was grantednot a trade | Acasti Pharmaderivative | 41,668 shares | up +3.7% | down −0.9% |
| 14 Jul 2023 | 18 Jul 2023SEC Form 4 | 4 d | was grantednot a trade | Acasti Pharmaderivative | 208,334 shares | down −11.2% | down −11.6% |
Both percentages are the stock’s move, not Prashant Kohli’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 6 of the 6 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.